Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Tsai

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Vaccine|May 24, 2000
New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998T F Tsai
The British Journal of Dermatology|September 14, 2013
Hepatitis B virus reactivation after ustekinumab treatment: reply from authorsT-F Tsai
The British Journal of Dermatology|March 18, 2021
Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasisT-F Tsai
Bulletin of the World Health Organization|March 4, 1999
Yellow feverT F Tsai
Laboratory Animal Science|August 1, 1987
Hemorrhagic fever with renal syndrome: clinical aspectsT F Tsai
The New England Journal of Medicine|April 4, 1985
Possible modes of transmission of Creutzfeldt-Jakob diseaseT F Tsai
Infectious Disease Clinics of North America|March 1, 1991
Arboviral infections in the United StatesT F Tsai
Laboratory Animal Science|August 1, 1987
Hemorrhagic fever with renal syndrome: mode of transmission to humansT F Tsai
The British Journal of Dermatology|February 5, 2020
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatmentT-F Tsai
The British Journal of Dermatology|May 31, 2019
Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case seriesY Lo, T-F Tsai
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Vaccine|May 24, 2000
New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998T F Tsai
The British Journal of Dermatology|September 14, 2013
Hepatitis B virus reactivation after ustekinumab treatment: reply from authorsT-F Tsai
The British Journal of Dermatology|March 18, 2021
Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasisT-F Tsai
Bulletin of the World Health Organization|March 4, 1999
Yellow feverT F Tsai
Laboratory Animal Science|August 1, 1987
Hemorrhagic fever with renal syndrome: clinical aspectsT F Tsai
The New England Journal of Medicine|April 4, 1985
Possible modes of transmission of Creutzfeldt-Jakob diseaseT F Tsai
Infectious Disease Clinics of North America|March 1, 1991
Arboviral infections in the United StatesT F Tsai
Laboratory Animal Science|August 1, 1987
Hemorrhagic fever with renal syndrome: mode of transmission to humansT F Tsai
The British Journal of Dermatology|February 5, 2020
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatmentT-F Tsai
The British Journal of Dermatology|May 31, 2019
Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case seriesY Lo, T-F Tsai
Pageof 21